Work

Phase III trial comparing 3–6 months of adjuvant FOLFOX4/XELOX in stage II–III colon cancer: safety and compliance in the TOSCA trial

Year: 2016
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2507511969
FWCI: 3.858
Cites: 13
Cited by: 59
Related to: 10